YOĞUN BAKIM ÜNİTELERİNDEN İZOLE EDİLEN PSEUDOMONAS AERUGİNOSA SUŞLARININ ANTİBİYOTİKLERE DUYARLILIKLARI

dc.contributor.authorErdoğan, Mehmet Mustafa
dc.contributor.authorDelen, Leman Acun
dc.contributor.authorErdoğan, Esra
dc.date.accessioned2022-02-08T13:55:35Z
dc.date.available2022-02-08T13:55:35Z
dc.date.issued2021
dc.departmentİnönü Üniversitesien_US
dc.description.abstractÖz: Pseudomonas aeruginosastrains are frequently isolated, especially from inpatient samples in intensive care units. These strains lead to infections that are difficult to treat due to antibiotic resistance, thus increasing morbidity and mortality. The aim of this study is to determine the resistance of P. aeruginosaisolates, isolated from intensive care patients of Malatya Training and Research Hospital, to various antibiotics. P. aeruginosastrains isolated from various clinical samples of patients who were followed up in intensive care units of Malatya Training and Research Hospital between July 2016 and July 2019, were included in the study. Identification and in vitro antibiotic susceptibility of the strains were determined using Vitek 2 automated system (bioMérieux, France). Of the 468 P. aeruginosastrains included in the study, 51.7% were isolated from respiratory tract samples, followed by urine samples with 31.2% and, abscess and wound samples with 9%. Colistin and norfloxacin were determined to be the most effective antibiotics for P. aeruginosastrains, while the lowest susceptibility was determined for aztreonam among the studied antibiotics. Susceptibility rates were determined to be; 76.5% for amikacin, 8.1% for aztreonam, 74.4% for gentamicin, 62.2% for imipenem, 97.1% for colistin, 57.5% for levofloxacin, 61.4% for meropenem, 57.4% for netilmisin, 89.9% for norfloxacin, 48.7% for piperacillin/tazobactam, 35.7% for piperacillin, 57.7% for cefepime, 62.7% for ceftazidime, 66% for ciprofloxacin, and 80.9% for tobramycin. In order to develop effective and accurate infection control strategies and reduce morbidity and mortality, it is important to know the distribution and susceptibility of infectious agents, especially in critical patients in intensive care units.en_US
dc.identifier.citationERDOĞAN M. M,DELEN L. A,ERDOĞAN E (2021). YOĞUN BAKIM ÜNİTELERİNDEN İZOLE EDİLEN PSEUDOMONAS AERUGİNOSA SUŞLARININ ANTİBİYOTİKLERE DUYARLILIKLARI. İnönü üniversitesi Sağlık Hizmetleri Meslek Yüksek Okulu Dergisi, 9(1), 230 - 237. Doi: :10.33715/inonusaglik.826224en_US
dc.identifier.doi10.33715/inonusaglik.826224en_US
dc.identifier.endpage237en_US
dc.identifier.issn2147-7892
dc.identifier.issue1en_US
dc.identifier.startpage230en_US
dc.identifier.trdizinid427977en_US
dc.identifier.urihttps://doi.org/10.33715/inonusaglik.826224
dc.identifier.urihttps://hdl.handle.net/11616/46900
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/427977
dc.identifier.volume9en_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isotren_US
dc.relation.ispartofİnönü Üniversitesi Sağlık Hizmetleri Meslek Yüksek Okulu Dergisien_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleYOĞUN BAKIM ÜNİTELERİNDEN İZOLE EDİLEN PSEUDOMONAS AERUGİNOSA SUŞLARININ ANTİBİYOTİKLERE DUYARLILIKLARIen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
3ff9ea59-07a2-48bc-8304-25d9a1283182.pdf
Boyut:
428.15 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.71 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: